{"id":"W2157539481","doi":"10.1086/591705","title":"Safety, Tolerability, and Preliminary Efficacy of 48 Weeks of Etravirine Therapy in a Phase IIb Dose‐Ranging Study Involving Treatment‐Experienced Patients with HIV‐1 Infection","year":2008,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; St. Paul's Hospital; University of British Columbia Hospital","funders":"","keywords":"Tolerability; Medicine; Placebo; Etravirine; Internal medicine; Adverse effect; Regimen; Rash; Gastroenterology; Dose-ranging study; Viral load; Pharmacology; Human immunodeficiency virus (HIV); Immunology; Antiretroviral therapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002978363,0.001339758,0.001634439,0.0003099083,0.0003478091,0.0006493166,0.0006909483,0.001199181,0.002319301],"category_scores_gemma":[0.002127602,0.0006271319,0.001159928,0.0003146092,0.0006004285,0.0006866532,0.0002530331,0.002153786,0.0004522055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003940223,"about_ca_system_score_gemma":0.0005825487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002765268,"about_ca_topic_score_gemma":0.0005950125,"domain_scores_codex":[0.9986556,0.0009814362,0.00006682605,0.0001219103,0.0000721582,0.0001021073],"domain_scores_gemma":[0.9987513,0.0003770597,0.0003489779,0.0001360684,0.00006878818,0.0003177959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8486139,0.04860036,0.006722793,0.000463687,0.0008771282,0.0001716924,0.0003000505,0.001631304,0.03171477,0.00008806893,0.0008618739,0.05995446],"study_design_scores_gemma":[0.4649541,0.5164297,0.01430287,0.00002968648,0.0003075041,0.0001455777,0.00002985464,0.0006595671,0.002355252,0.00006989298,0.0006884681,0.000027479],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974903,0.0008575721,0.0002445071,0.00009532678,0.0000264947,0.0005705465,0.0001744435,0.00002451243,0.0005163274],"genre_scores_gemma":[0.9958235,0.0005931117,0.001009913,0.0003459445,0.0001067704,0.00107038,0.0004310945,0.00001106205,0.0006082652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002978363,"threshold_uncertainty_score":0.0157513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03664855972347149,"score_gpt":0.3584581727088652,"score_spread":0.3218096129853937,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}